PHARMACOECONOMIC STUDY OVER USE OF ANTICHOLINERGIC BRONCHODILATORS (SPIRIVA AND ATROVENT) FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

by A. U. Kulikov, I. A. Komarov
Published 2015-03-01

COST-EFFECTIVENESS ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE...

by R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov
Published 2015-03-01

COST-UTILITY ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO...

by R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov
Published 2015-03-01

Optimization of RHDV type 1 and 2 inactivation modes

by E. D. Kunikova, N. V. Moroz, M. A. Dolgova, L. V. Malakhova, I. A. Komarov
Published 2021-03-01